ACCP Podcast

The American College of Clinical Pharmacy uses this feed for a resident-led interview series that calls itself a podcast 'for residents by residents,' and the phrase describes how it works. One pharmacy resident talks with one guest. Christian Kroll, a PGY-2 emergency medicine clinical pharmacy resident at UW Health in Madison, conducts several of the recent conversations, and he likes to begin by asking guests to trace their pharmacy careers so far. After that, the talk turns to evidence and stays there. With Dr. Julie Farah, a critical care pharmacy resident at the University of Colorado, the subject is ventilator synchrony in severe ARDS and the point where deeper sedation gives way to continuous neuromuscular blockade. Kroll adds that he has seen more paralytics in recent months than he could count. He then sets the older professional-society support for continuous infusions against the ROSE trial, which found no improvement in important patient outcomes over as-needed intermittent boluses. The Surviving Sepsis COVID-19 guidelines come in too, reserving paralytic drips for patients whom intermittent dosing may not serve. Other episodes move into other specialties. Dr. Megan Klatt, a PGY-2 infectious disease resident at Michigan Medicine who did her PGY-1 alongside Kroll at UW Health, takes on oral agents for known gram-negative bacteremia. The case for sulfamethoxazole-trimethoprim and fluoroquinolones as oral step-down options rests on bioavailability and bactericidal killing, with a quick refresher on what bioavailability means and a nod to fluoroquinolone risks such as C. difficile infection. Dr. Ted Berry of the UW Health cardiology department traces how SGLT2 inhibitors moved into the heart failure spotlight. The discussion cites EMPA-REG in 2015, where only a small share of patients had a heart failure diagnosis, and the CANVAS data in patients with ASCVD and diabetes. Some conversations leave the bedside altogether. Dr. Kristen Bamberg, lead critical care pharmacist at Northern Arizona Healthcare, explains what pharmacist board certification is and how BPS has shifted from portfolio-based added qualifications toward exams for individual specialties. She points to ACCP's prodding in the mid-2000s as a spur for that review and describes the petitions and role delineation studies that followed, down to a certification in compounded sterile preparation. In another episode, Monica, a PGY-1 pharmacy resident at Avera McKinnon Hospital and University Health Center, talks with Dr. Brad Libley, a professor at South Dakota State University and the antimicrobial stewardship pharmacist at Avera McKinnon. Their subject is running stewardship across a rural health system. Libley's point is practical: even simple standards such as IV-to-PO switches and renal dosing needed buy-in from pharmacists and facility leadership across the system. The register throughout is collegial and technical, and trial names, drug classes and acronyms come thick and fast. Episodes close by pointing to ACCP's online resources for residents and fellows. What a listener takes away is a peer's-eye view of current evidence and a clearer sense of how specialty training and credentials in clinical pharmacy fit together.